NP / PA
Nardine Assaad, MD, LLC
Nardine Assaad, MD, LLC was paid $1.45M by Medicaid between Jul 2020 and Dec 2024, across 42 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 51% of everything it billed.
33Billing provider infoNARDINE ASSAAD, MD, LLC
TOWSON, MD 21204
TOWSON, MD 21204
33aNPI1154955862assigned 03/03/2020
33bProvider typePsychiatric/Mental Health Nurse Practitioner
28Total paid$1.45M
24GClaims31,024
24DCodes billed42
24AFirst – last monthJul 2020 – Dec 2024
Compared with peers
Next to other Psychiatric/Mental Health Nurse Practitioner providers in Maryland
Rank by total paid#9 of 298
Median peer was paid$67K
This provider vs. median22×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 161 | $4K | |
| 2021 | 3,821 | $168K | |
| 2022 | 7,783 | $349K | |
| 2023 | 8,842 | $446K | |
| 2024incomplete | 10,417 | $481K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 51% | 9,766 | 7,926 | $734K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 9.7% | 1,344 | 1,272 | $140K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 8.6% | 1,289 | 1,183 | $124K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 4.9% | 685 | 656 | $71K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 4.3% | 589 | 470 | $62K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 3.9% | 455 | 412 | $57K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 2.8% | 1,082 | 940 | $41K |
| 92552 | 2.7% | 1,760 | 1,623 | $39K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 2.4% | 4,185 | 3,763 | $34K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 2.1% | 259 | 252 | $31K |
| 90677 | 1.1% | 311 | 297 | $16K | |
| 90686 | <1% | 757 | 691 | $14K |
30 more codes
| 90670 | <1% | 580 | $13K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 253 | $10K |
| 90723 | <1% | 466 | $10K | |
| 90647 | <1% | 460 | $9K | |
| 99383 | <1% | 52 | $6K | |
| 99173 | <1% | 2,550 | $6K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 306 | $4K |
| 99382 | <1% | 35 | $4K | |
| 90656 | <1% | 146 | $3K | |
| 87428 | <1% | 148 | $3K | |
| 90633 | <1% | 110 | $2K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 34 | $2K |
| 99381 | <1% | 12 | $1K | |
| 96161 | <1% | 565 | $1K | |
| 96160 | <1% | 544 | $1K | |
| 90681 | <1% | 64 | $1K | |
| 90697 | <1% | 43 | $1K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 41 | $890.59 |
| 90688 | <1% | 66 | $861.36 | |
| 90734 | <1% | 35 | $744.96 | |
| 0071A | <1% | 18 | $723.00 | |
| 0072A | <1% | 16 | $640.98 | |
| 90710 | <1% | 29 | $605.28 | |
| 90651 | <1% | 24 | $535.44 | |
| 90700 | <1% | 13 | $302.64 | |
| 96127 | <1% | 63 | $284.77 | |
| 87807 | <1% | 25 | $240.88 | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 0% | 42 | $0.00 |
| 91307 | 0% | 15 | $0.00 | |
| G9920 | Screening performed and negative | 0% | 1,787 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialASSAAD, NARDINE (OWNER)